Analysing uric acid levels to assess the effectiveness of dapagliflozin

Author:

Rajasekar R.,Sundaram Sivaraj MohanaORCID,Raj C. Poornima,Poovitha M.,Kumar Janardanan Subramonia

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Insulin action and resistance in obesity and type 2 diabetes;Czech;Nat Med,2017

2. Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes;Nguyen;Diabetes Obes Metabol,2023

3. Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study;Morieri;J Endocrinol Invest,2023

4. Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial);Kuchay;Acta Diabetol,2023

5. Effect of dapagliflozin on urine metabolome in patients with type 2 diabetes;Bletsa;J Clin Endocrinol Metab,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3